Moberg Pharma AB sell BiotechBee
Start price
13.05.24
/
70%
€2.37
Target price
31.05.26
€1.50
Performance (%)
-0.84%
End price
14.05.24
€2.35
Summary
This prediction ended on 14.05.24 with a price of €2.35. From the start of the prediction for Moberg Pharma AB the price only changed by -0.84%. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Moberg Pharma AB | 0.298% | 0.298% | 3.756% |
| iShares Core DAX® | -1.764% | 2.259% | 15.213% |
| iShares Nasdaq 100 | -1.632% | -0.193% | 3.293% |
| iShares Nikkei 225® | -2.451% | 4.086% | 17.198% |
| iShares S&P 500 | -2.252% | -0.151% | 0.574% |
According to BiotechBee what are the pros and cons of Moberg Pharma AB for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year